HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by HEMSELL, D. L. Articles by NOBLES, B. J. Search for Related Content PubMed PubMed Citation Articles by HEMSELL, D. L. Articles by NOBLES, B. J.

Cefoperazone and Cefoxitin Prophylaxis for Abdominal Hysterectomy

From the Departments of Obstetrics and Gynecology and of Anesthesia, The University of Texas Health Science Center at Dallas, Southwestern Medical School, and Parkland Memorial Hospital, Dallas Texas

Abstract

One hundred one women undergoing elective abdominal hysterectomy were given perioperative cefoperazone or cefoxitin in a prospective randomized blinded study. Both regimens were well tolerated and no significant toxic or allergic manifestations were observed. Interrelationships between antimicrobial concentration in serum and pelvic tissues, intraoperative cardinal ligament cultures, febrile morbidity, and major postoperative infection were determined. At uterine removal, mean cefoperazone concentrations in serum (56.1µg/mL) and pelvic tissues (18.6 n-g/g) were significantly higher than mean concentrations of cefoxitin, ie, 16.1 µg/mL and 8.1 µg/g, respectively (P<.001). The incidence of major postoperative infection was 6% or less with both regimens. Perioperative prophylaxis significantly reduced the incidence of this infection. When it did develop, however, it continued to cause significant morbidity, prolonging hospital stay a mean of more than four days (P<.001) and increasing the hospital bill a mean of almost $1500 (P<.001).